Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis

Vittorio Magri, Alberto Trinchieri, Giacomo Pozzi, Antonella Restelli, Maria Cristina Garlaschi, Erminio Torresani, Pasquale Zirpoli, Emanuela Marras, Gianpaolo Perletti

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A total of 137 patients with a diagnosis of chronic bacterial prostatitis (CBP) were subjected to combination pharmacological therapy with antibacterial agents (ciprofloxacin/azithromycin), alpha-blockers (alfuzosin) and Serenoa repens extracts. Of those, 88 patients (64.2%) showed microbiological eradication at the completion of a 6-week cycle of therapy. Of the remaining 49 patients showing persistence of the causative organism(s) or reinfection at the end of treatment, 36 completed a second cycle of combination therapy for 6 weeks: 27 patients (75%) showed eradication of the causative organism, whereas in nine cases persistence or reinfection was observed. The cumulative eradication rate of the present study - calculated on a total of 137 enrolled patients - is 83.9%. Clinical examination showed a marked improvement of signs and symptoms linked to prostatitis. Remarkably, combination therapy could attenuate CBP symptoms prior to microbiological eradication, thus rapidly decreasing the impact of the disease on the quality of life of patients. Clinical remission was extended throughout a follow-up period of 30 months for 94% of patients, whereas seven patients showed relapse of the disease. In summary, our results indicate that about 20% of patients enrolled in this study, who were refractory to a protocol of 6-week combination therapy, could be 'rescued' by a second cycle of treatment. Clinical follow-up data show that combination therapy could ensure extended relief from CBP symptoms, and a general improvement in quality of life.

Original languageEnglish
Pages (from-to)549-556
Number of pages8
JournalInternational Journal of Antimicrobial Agents
Volume29
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Prostatitis
Therapeutics
Quality of Life
Azithromycin
Ciprofloxacin
Signs and Symptoms
Pharmacology
Anti-Bacterial Agents
Recurrence

Keywords

  • Alfuzosin
  • Azythromicin
  • Chronic bacterial prostatitis
  • Ciprofloxacin
  • NIH-CPSI
  • Serenoa repens

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. / Magri, Vittorio; Trinchieri, Alberto; Pozzi, Giacomo; Restelli, Antonella; Garlaschi, Maria Cristina; Torresani, Erminio; Zirpoli, Pasquale; Marras, Emanuela; Perletti, Gianpaolo.

In: International Journal of Antimicrobial Agents, Vol. 29, No. 5, 05.2007, p. 549-556.

Research output: Contribution to journalArticle

Magri, V, Trinchieri, A, Pozzi, G, Restelli, A, Garlaschi, MC, Torresani, E, Zirpoli, P, Marras, E & Perletti, G 2007, 'Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis', International Journal of Antimicrobial Agents, vol. 29, no. 5, pp. 549-556. https://doi.org/10.1016/j.ijantimicag.2006.09.027
Magri, Vittorio ; Trinchieri, Alberto ; Pozzi, Giacomo ; Restelli, Antonella ; Garlaschi, Maria Cristina ; Torresani, Erminio ; Zirpoli, Pasquale ; Marras, Emanuela ; Perletti, Gianpaolo. / Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. In: International Journal of Antimicrobial Agents. 2007 ; Vol. 29, No. 5. pp. 549-556.
@article{6e65c1074dbd4095938bdc238c28a98e,
title = "Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis",
abstract = "A total of 137 patients with a diagnosis of chronic bacterial prostatitis (CBP) were subjected to combination pharmacological therapy with antibacterial agents (ciprofloxacin/azithromycin), alpha-blockers (alfuzosin) and Serenoa repens extracts. Of those, 88 patients (64.2{\%}) showed microbiological eradication at the completion of a 6-week cycle of therapy. Of the remaining 49 patients showing persistence of the causative organism(s) or reinfection at the end of treatment, 36 completed a second cycle of combination therapy for 6 weeks: 27 patients (75{\%}) showed eradication of the causative organism, whereas in nine cases persistence or reinfection was observed. The cumulative eradication rate of the present study - calculated on a total of 137 enrolled patients - is 83.9{\%}. Clinical examination showed a marked improvement of signs and symptoms linked to prostatitis. Remarkably, combination therapy could attenuate CBP symptoms prior to microbiological eradication, thus rapidly decreasing the impact of the disease on the quality of life of patients. Clinical remission was extended throughout a follow-up period of 30 months for 94{\%} of patients, whereas seven patients showed relapse of the disease. In summary, our results indicate that about 20{\%} of patients enrolled in this study, who were refractory to a protocol of 6-week combination therapy, could be 'rescued' by a second cycle of treatment. Clinical follow-up data show that combination therapy could ensure extended relief from CBP symptoms, and a general improvement in quality of life.",
keywords = "Alfuzosin, Azythromicin, Chronic bacterial prostatitis, Ciprofloxacin, NIH-CPSI, Serenoa repens",
author = "Vittorio Magri and Alberto Trinchieri and Giacomo Pozzi and Antonella Restelli and Garlaschi, {Maria Cristina} and Erminio Torresani and Pasquale Zirpoli and Emanuela Marras and Gianpaolo Perletti",
year = "2007",
month = "5",
doi = "10.1016/j.ijantimicag.2006.09.027",
language = "English",
volume = "29",
pages = "549--556",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis

AU - Magri, Vittorio

AU - Trinchieri, Alberto

AU - Pozzi, Giacomo

AU - Restelli, Antonella

AU - Garlaschi, Maria Cristina

AU - Torresani, Erminio

AU - Zirpoli, Pasquale

AU - Marras, Emanuela

AU - Perletti, Gianpaolo

PY - 2007/5

Y1 - 2007/5

N2 - A total of 137 patients with a diagnosis of chronic bacterial prostatitis (CBP) were subjected to combination pharmacological therapy with antibacterial agents (ciprofloxacin/azithromycin), alpha-blockers (alfuzosin) and Serenoa repens extracts. Of those, 88 patients (64.2%) showed microbiological eradication at the completion of a 6-week cycle of therapy. Of the remaining 49 patients showing persistence of the causative organism(s) or reinfection at the end of treatment, 36 completed a second cycle of combination therapy for 6 weeks: 27 patients (75%) showed eradication of the causative organism, whereas in nine cases persistence or reinfection was observed. The cumulative eradication rate of the present study - calculated on a total of 137 enrolled patients - is 83.9%. Clinical examination showed a marked improvement of signs and symptoms linked to prostatitis. Remarkably, combination therapy could attenuate CBP symptoms prior to microbiological eradication, thus rapidly decreasing the impact of the disease on the quality of life of patients. Clinical remission was extended throughout a follow-up period of 30 months for 94% of patients, whereas seven patients showed relapse of the disease. In summary, our results indicate that about 20% of patients enrolled in this study, who were refractory to a protocol of 6-week combination therapy, could be 'rescued' by a second cycle of treatment. Clinical follow-up data show that combination therapy could ensure extended relief from CBP symptoms, and a general improvement in quality of life.

AB - A total of 137 patients with a diagnosis of chronic bacterial prostatitis (CBP) were subjected to combination pharmacological therapy with antibacterial agents (ciprofloxacin/azithromycin), alpha-blockers (alfuzosin) and Serenoa repens extracts. Of those, 88 patients (64.2%) showed microbiological eradication at the completion of a 6-week cycle of therapy. Of the remaining 49 patients showing persistence of the causative organism(s) or reinfection at the end of treatment, 36 completed a second cycle of combination therapy for 6 weeks: 27 patients (75%) showed eradication of the causative organism, whereas in nine cases persistence or reinfection was observed. The cumulative eradication rate of the present study - calculated on a total of 137 enrolled patients - is 83.9%. Clinical examination showed a marked improvement of signs and symptoms linked to prostatitis. Remarkably, combination therapy could attenuate CBP symptoms prior to microbiological eradication, thus rapidly decreasing the impact of the disease on the quality of life of patients. Clinical remission was extended throughout a follow-up period of 30 months for 94% of patients, whereas seven patients showed relapse of the disease. In summary, our results indicate that about 20% of patients enrolled in this study, who were refractory to a protocol of 6-week combination therapy, could be 'rescued' by a second cycle of treatment. Clinical follow-up data show that combination therapy could ensure extended relief from CBP symptoms, and a general improvement in quality of life.

KW - Alfuzosin

KW - Azythromicin

KW - Chronic bacterial prostatitis

KW - Ciprofloxacin

KW - NIH-CPSI

KW - Serenoa repens

UR - http://www.scopus.com/inward/record.url?scp=34147216759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147216759&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2006.09.027

DO - 10.1016/j.ijantimicag.2006.09.027

M3 - Article

VL - 29

SP - 549

EP - 556

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 5

ER -